Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Enasidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Enasidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Ensartinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Ensartinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Entrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Entrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Erdafitinib	FGFR Inhibitor	Solid Tumour
Molecule Erdafitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Erlotinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Erlotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Famitinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Famitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fexagratinib	FGFR Inhibitor	Solid Tumour
Molecule Fexagratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Fluzoparib	PARP Inhibitor	Solid Tumour
Molecule Fluzoparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Foretinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Foretinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fruquintinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Fruquintinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Furmonertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Furmonertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Futibatinib	FGFR Inhibitor	Solid Tumour
Molecule Futibatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor

Enasidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Ensartinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Entrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Erdafitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Erlotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Famitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fexagratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Fluzoparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor
Foretinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Fruquintinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Furmonertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Futibatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor

‹ 1 … 3 4 5 6 7 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Enasidenib

Ensartinib

Entrectinib

Erdafitinib

Erlotinib

Famitinib

Fexagratinib

Fluzoparib

Foretinib

Fruquintinib

Furmonertinib

Futibatinib

Enasidenib

Ensartinib

Entrectinib

Erdafitinib

Erlotinib

Famitinib

Fexagratinib

Fluzoparib

Foretinib

Fruquintinib

Furmonertinib

Futibatinib